This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2014.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here. NxStage Medical next reports earnings on July 21, 2014.
To receive a free e-mail notification whenever NxStage Medical makes a similar move, sign up!
Other recent filings from the company include the following:
NxStage: Termination Of A Material Definitive Agreement - Oct. 29, 2014
NxStage Medical's President just disposed of 1,000 shares - Oct. 24, 2014
President of NxStage Medical just cashed-in 45,370 options - Oct. 24, 2014
NxStage Medical's CEO just disposed of 7,584 shares - Oct. 22, 2014
NxStage Medical's President just disposed of 1,500 shares - Oct. 21, 2014